Insider Transactions in Q1 2022 at Neogenomics Inc (NEO)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 08
2022
|
William Bonello Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+4.61%
|
$35,000
$7.52 P/Share
|
|
Mar 07
2022
|
William Bonello Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,209
-3.15%
|
$57,762
$18.29 P/Share
|
|
Mar 02
2022
|
Douglas Matthew Brown Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
867
-1.12%
|
-
|
|
Mar 02
2022
|
William Bonello Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
620
-0.61%
|
-
|
|
Mar 02
2022
|
George Cardoza President & COO, Lab Ops |
SELL
Payment of exercise price or tax liability
|
Direct |
839
-0.34%
|
-
|
|
Mar 02
2022
|
Cynthia J Dieter Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
137
-0.73%
|
-
|
|
Mar 01
2022
|
Gina M Wallar President, Pharma Services |
BUY
Grant, award, or other acquisition
|
Direct |
11,677
+25.88%
|
-
|
|
Mar 01
2022
|
Douglas Matthew Brown Chief Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,030
+31.2%
|
-
|
|
Mar 01
2022
|
William Bonello Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
397
-0.39%
|
-
|
|
Mar 01
2022
|
William Bonello Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,869
+28.46%
|
-
|
|
Mar 01
2022
|
George Cardoza President & COO, Lab Ops |
SELL
Payment of exercise price or tax liability
|
Direct |
503
-0.2%
|
-
|
|
Mar 01
2022
|
Cynthia J Dieter Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,341
+33.22%
|
-
|
|
Mar 01
2022
|
Mark Mallon Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
142,457
+27.9%
|
-
|
|
Mar 01
2022
|
Halley E Gilbert Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
42,036
+22.19%
|
-
|
|
Jan 11
2022
|
Kathryn B Mc Kenzie Chief Sustainability/Risk Ofcr |
BUY
Exercise of conversion of derivative security
|
Direct |
2,100
+4.08%
|
$18,900
$9.07 P/Share
|